📌 Key Takeaways
- A survey published in January 2026 (n=411, conducted December 2025) found only ~30% of aesthetic medicine patients in Japan maintain monthly or more frequent clinic visits.
- 45% of respondents cited “access to a trusted physician on an ongoing basis” as the most important factor for continuation.
- 95% expressed interest in a “primary care-style” aesthetic medicine model — yet the majority still drop out.
- The top three dropout drivers are cost, scheduling friction, and unclear treatment rationale — all structural, not personal.
Starting aesthetic medicine is easy.
Continuing it is not.
A survey conducted in December 2025 and published in January 2026 by Neautech Co., Ltd. — covering 411 respondents aged 20 to 60 with experience or interest in aesthetic medicine — found that only approximately 30% of patients maintain regular monthly clinic visits.
That means 7 in 10 patients drop out before establishing a consistent treatment rhythm.
The same survey revealed two additional findings that define the structural tension:
45.0% of respondents named “access to a trusted physician on a continuing basis” as the single most important factor for staying the course.
And 95% said they would use a service modeled on a “primary care physician for aesthetics” — a dedicated, ongoing relationship with a single provider.
The demand is there. The follow-through is not.
What explains this gap?
visit monthly or more
continuity” as top factor
aesthetics” model
Dropout from aesthetic medicine is not a willpower problem.
The survey data — combined with broader market research — points to three consistent structural barriers.
Cost — “I can afford one session, but not every month”
Patients can often absorb the cost of a single session.
What they cannot absorb is the cumulative cost of a monthly regimen —
because no one has helped them plan for it.
Clinics typically market the value of a single treatment,
not the architecture of a sustainable long-term plan.
Scheduling friction — “I’m too busy, and appointments are hard to get”
Most aesthetic clinics in Japan are concentrated in urban centers,
with evening and weekend slots in high demand.
When scheduling becomes a friction point,
patients simply stop trying.
Hybrid models combining in-person treatment with telehealth consultations
are emerging as a practical solution.
Unclear rationale — “I stopped understanding why I was continuing”
Many aesthetic treatments work on a “results diminish when you stop” model.
But if the physician never clearly explains why continuation matters,
patients rationalize quitting: “Maybe nothing would change anyway.”
Making skin improvement visible — through photos, scores, and data —
is one of the most effective tools for sustaining motivation.
The continuation problem matters precisely because Japan’s aesthetic medicine market is expanding rapidly.
Procedure volumes are rising across the market.
Yet the January 2026 survey found that only ~30% of patients maintain monthly visits.
These two datasets track different populations and cannot be directly compared —
but together they suggest a pattern: the market is growing, yet regular continuation remains the exception, not the norm.
For clinic operators, this implies a structural challenge: rising acquisition costs paired with low patient retention.
Clinics and services that have deliberately engineered for continuation
report that over 90% of first-time patients return for a second visit.
What separates them from the rest?
Strategy 1 — Book the next appointment before the patient leaves
Telling a patient “come back in four weeks” is not enough.
Dropout almost always happens when the next visit is left unscheduled.
Confirming the next appointment at the end of every session
is one of the simplest and most effective retention mechanisms.
Strategy 2 — Make progress visible
Before-and-after photos, skin scores, and measurable data
give patients a concrete reason to continue.
Most aesthetic treatments accumulate benefit over time —
without visible evidence of that progress,
patients lose the motivation to return.
Strategy 3 — Hybrid care: in-person treatment + telehealth check-ins
Combining monthly in-clinic sessions with mid-cycle online consultations
and at-home skincare guidance reduces the burden of attendance.
Evidence is accumulating that this hybrid model meaningfully improves retention.
- Cost is the barrier → Look for subscription-based or bundled treatment plans
- Scheduling is the barrier → Seek clinics offering telehealth consultation options
- “I lost track of why I was continuing” → Ask your physician directly: “How many sessions, and at what interval, do I actually need?”
- “I never knew when to come back” → Make it a habit to book your next appointment on the day of each visit
Continuation is harder than initiation — and that’s not unique to aesthetic medicine.
But the stakes here are particularly structural.
When 70% of patients drop out, clinics are effectively running on an endless acquisition treadmill:
high cost to attract new patients, low return from retaining them.
A 30% continuation rate is not just a patient experience problem —
it’s a business model problem.
The fix is less about technology and more about communication and system design.
When 95% of patients say they want a trusted, ongoing physician relationship,
and yet 70% still drop out —
the gap is not in demand. It’s in delivery.
Whoever builds the infrastructure to close that gap
will define the next chapter of aesthetic medicine.
Summary
- A December 2025 survey (published January 2026, n=411) found that only ~30% of aesthetic medicine patients in Japan maintain monthly or more frequent clinic visits — meaning 7 in 10 drop out before establishing a regular rhythm.
- The top three dropout drivers are cost (74.7%), scheduling burden (34.3%), and unclear treatment rationale (25.3%) — all structural, not personal failures.
- Market data shows procedure volumes at JSAPS member facilities grew approximately 1.5× between 2019 and 2023; HotPepper Beauty Academy data shows a 77.1% repeat experience rate among men in their 20s — though this includes different treatments and different clinics, and is not a retention rate.
- The structural paradox: the market is expanding, yet regular continuation remains a minority behavior. For clinics, this means rising acquisition costs against a backdrop of low patient retention.
- Proven retention strategies include same-day rebooking, visible progress tracking, and hybrid in-person/telehealth models. Clinics that implement these report over 90% second-visit rates.
Frequently Asked Questions
Hyaluronic acid fillers and botulinum toxin naturally diminish over 6–12 months, making continuation inherent to the treatment model.
Biostimulators such as Sculptra and Radiesse stimulate collagen production and typically require a series of sessions followed by periodic maintenance.
Laser toning and skin boosters are also designed to accumulate benefit over repeated sessions.
Judging a treatment as ineffective after a single session is premature — ask your physician directly how many sessions are recommended and at what interval.
Source: Neautech, “Survey on Skin Investment and Aesthetic Medicine Continuation” (conducted Dec 2025, published Jan 2026)
① Prioritize: focus on the one area or treatment with the highest personal impact rather than pursuing everything at once.
② Seek subscription or bundled plans: an increasing number of clinics offer monthly membership models that reduce per-session cost.
③ Extend treatment intervals with home care: clinician-prescribed skincare routines can prolong the effects of in-clinic treatments.
④ Use telehealth for mid-cycle check-ins: on months when in-person visits aren’t feasible, an online consultation keeps the care relationship active without the full cost of a session.
Sources: Neautech survey (Jan 2026); HotPepper Beauty Academy “Beauty Census H2 2025”
The January 2026 survey found that 95% of respondents expressed interest in this model.
Its significance lies in shifting aesthetic medicine from a transactional, event-based experience to a continuous healthcare relationship — one that improves both outcomes and retention.
Clinics that operationalize this model through consistent physician assignment, progress tracking, and hybrid care delivery are positioned to lead the next phase of market development.
Sources
1. Neautech Co., Ltd. “Survey on Skin Investment and Aesthetic Medicine Continuation.” PR TIMES. Published January 20, 2026. (Conducted December 2–8, 2025; n=411; online survey)
2. HotPepper Beauty Academy. “Beauty Census H2 2025: Aesthetic Medicine Edition — Consumer Awareness Survey.” December 2025. (Note: 77.1% reflects “repeat experience rate,” which includes different treatments and different clinics; this is not equivalent to a retention rate.)
3. Japan Society of Aesthetic Plastic Surgery (JSAPS). “7th National Aesthetic Medicine Survey — Final Report.” 2025. (Note: figures reflect JSAPS member facilities only and do not represent the full market.)
4. Nikkei Business Special. “Japan’s Expanding Aesthetic Medicine Market: The Urgent Need for Quality and Safety.” 2025. (Underlying data: HotPepper Beauty Academy “Beauty Census”)
This article is an industry report produced by the NERO DOCTOR/BEAUTY editorial team based on publicly available primary sources. It does not constitute a recommendation of any specific clinic or service.
